Remdesivir 100mg InjectionInjection
Antiviral

Remdesivir 100mg Injection

Remdesivir

Nucleotide analog RNA polymerase inhibitor for hospitalized COVID-19 patients requiring supplemental oxygen. Manufactured by Cipla and Hetero for hospital export.

Strengths

100mg

Packing

1 vial/box

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Remdesivir 100mg lyophilized powder for IV infusion
Dosage Form
Injection
Available Strengths
100mg
Packing
1 vial/box
Route of Administration
Intravenous infusion over 30-120 minutes
Dosage
Day 1: 200mg IV loading dose; Days 2-5 (or 2-10): 100mg IV once daily
Indications
Hospitalized COVID-19 patients requiring supplemental oxygen, recent-onset COVID-19 in high-risk non-hospitalized patients
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C (lyophilized); 2-8°C (solution)
Shelf Life
24 months
Side Effects
Nausea, elevated transaminases, infusion-related reactions, bradycardia, rash
Precautions
Monitor hepatic function; eGFR monitoring; infusion reactions — slow rate if needed; not recommended if eGFR <30; monitor for bradycardia

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Remdesivir 100mg Injection?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote